California State Teachers Retirement System (CalSTRS)’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-68,729
Closed -$4.11M 3018
2019
Q4
$4.11M Sell
68,729
-1,389
-2% -$52.1K 0.01% 1138
2019
Q3
$1.97M Buy
70,118
+2,594
+4% +$88.5K ﹤0.01% 1529
2019
Q2
$2.56M Buy
67,524
+10,569
+19% +$406K 0.01% 1407
2019
Q1
$2.22M Sell
56,955
-1,267
-2% -$36.3K ﹤0.01% 1466
2018
Q4
$1.24M Buy
58,222
+8,460
+17% +$218K ﹤0.01% 1769
2018
Q3
$1.97M Buy
49,762
+762
+2% +$28.4K ﹤0.01% 1641
2018
Q2
$1.87M Buy
49,000
+18,433
+60% +$683K ﹤0.01% 1662
2018
Q1
$919K Buy
30,567
+4,666
+18% +$158K ﹤0.01% 2031
2017
Q4
$809K Buy
25,901
+1,187
+5% +$32.6K ﹤0.01% 2117
2017
Q3
$692K Sell
24,714
-2,286
-8% -$49.6K ﹤0.01% 2224
2017
Q2
$517K Buy
27,000
+15,200
+129% +$243K ﹤0.01% 2449
2017
Q1
$201K Hold
11,800
﹤0.01% 2819
2016
Q4
$216K Sell
11,800
-400
-3% -$6.91K ﹤0.01% 2847
2016
Q3
$217K Buy
+12,200
New +$185K ﹤0.01% 2855

California State Teachers Retirement System (CalSTRS)'s BOLD Position: Q1 2020 in Review

California State Teachers Retirement System (CalSTRS) sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 68,729 shares — an estimated $4.11M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in BOLD in Q3 2016 and held it in 14 quarters. The position peaked at $4.11M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 68,729 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.11M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 14 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Audentes Therapeutics, Inc position peaked at $4.11M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2020, filed 13 May 2020.